AU2001279127A1 - Methods and devices to modulate the wound response - Google Patents

Methods and devices to modulate the wound response

Info

Publication number
AU2001279127A1
AU2001279127A1 AU2001279127A AU7912701A AU2001279127A1 AU 2001279127 A1 AU2001279127 A1 AU 2001279127A1 AU 2001279127 A AU2001279127 A AU 2001279127A AU 7912701 A AU7912701 A AU 7912701A AU 2001279127 A1 AU2001279127 A1 AU 2001279127A1
Authority
AU
Australia
Prior art keywords
modulate
methods
devices
wound response
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279127A
Inventor
Paul Bornstein
Cecilia Giachelli
Themis Kyriakides
Laura Martinson
Buddy Ratner
Marta Scatena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of AU2001279127A1 publication Critical patent/AU2001279127A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific
AU2001279127A 2000-08-01 2001-07-31 Methods and devices to modulate the wound response Abandoned AU2001279127A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22207100P 2000-08-01 2000-08-01
US60/222,071 2000-08-01
PCT/US2001/024147 WO2002009735A2 (en) 2000-08-01 2001-07-31 Methods and devices to modulate the wound response

Publications (1)

Publication Number Publication Date
AU2001279127A1 true AU2001279127A1 (en) 2002-02-13

Family

ID=22830690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279127A Abandoned AU2001279127A1 (en) 2000-08-01 2001-07-31 Methods and devices to modulate the wound response

Country Status (3)

Country Link
US (1) US20020048577A1 (en)
AU (1) AU2001279127A1 (en)
WO (1) WO2002009735A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129214A1 (en) * 2002-01-10 2003-07-10 University Of Washington Methods of enhancing the biocompatibility of an implantable medical device
AU2003258127A1 (en) 2002-08-06 2004-02-23 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
US20060002969A1 (en) * 2004-01-27 2006-01-05 University Of Washington Methods for reducing the foreign body reaction
JP2009519254A (en) * 2005-12-16 2009-05-14 アルラ・フーズ・エイ・エム・ビィ・エイ Bovine osteopontin formulation to improve wound healing process
US9517023B2 (en) 2009-06-01 2016-12-13 Profusa, Inc. Method and system for directing a localized biological response to an implant
US10010272B2 (en) 2010-05-27 2018-07-03 Profusa, Inc. Tissue-integrating electronic apparatus
CN103260501B (en) 2010-10-06 2015-09-02 普罗弗萨股份有限公司 Tissue integration sensor
CA2904031A1 (en) 2013-03-14 2014-10-02 Profusa, Inc. Method and device for correcting optical signals
CN105307559B (en) 2013-06-06 2020-06-05 普罗菲尤萨股份有限公司 Apparatus and method for detecting optical signals from implanted sensors
WO2015127061A1 (en) 2014-02-19 2015-08-27 The Regents Of The University Of California Colostrum/milk protein compositions
SG10201902499VA (en) 2014-09-03 2019-04-29 Genesegues Inc Therapeutic nanoparticles and related compositions, methods and systems
EP3448310A4 (en) * 2016-04-27 2019-12-18 Yale University Compositions and methods for grafts modified with a non-thrombogenic and pro-migratory cell-derived extracellular matrix
US11331018B2 (en) 2016-12-22 2022-05-17 Profusa, Inc. System and single-channel biosensor for and method of determining analyte value

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558697A1 (en) * 1991-06-28 1993-09-08 Massachusetts Institute Of Technology Localized oligonucleotide therapy
AU748002B2 (en) * 1997-12-31 2002-05-30 Depuy Orthopaedics, Inc. Osteopontin-based compositions for enhancing bone repair
EP1171151A4 (en) * 1999-03-31 2004-08-04 Gen Hospital Corp Thrombospondin-2 and uses thereof

Also Published As

Publication number Publication date
WO2002009735A2 (en) 2002-02-07
US20020048577A1 (en) 2002-04-25
WO2002009735A3 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU2001276030A1 (en) Novel wound irrigation device and method
AU2001285409A1 (en) Memory devices and methods for use therewith
AU2001247770A1 (en) Biased rotatable combdrive devices and methods
AU3620600A (en) Skin-marking devices and their use
AU2001228310A1 (en) Rear-projecting device
AU2002303927A1 (en) Methods and apparatuses to identify devices
AU2001276546A1 (en) An electro-optic device
AU2001242970A1 (en) Information-related devices and methods
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001252985A1 (en) Methods and devices to control polymerization
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001279127A1 (en) Methods and devices to modulate the wound response
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
EP1180823A3 (en) Cable-connection or cable-joint device
AU2001225491A1 (en) Streak device
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002224311A1 (en) Winding device
AU2001248824A1 (en) Thermotherapy device
AU2001253461A1 (en) Coated anchoring device
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2001241311A1 (en) Cap-signaling device
AU2001254745A1 (en) Pellet-freezing device
AU2001277695A1 (en) Remote-controlled device
AU2001250678A1 (en) Holder-grasping device
AU2001238543A1 (en) Antiextrusion device